Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain

M Waelbroeck, M Tastenoy, J Camus and J Christophe

Department of Biochemistry and Nutrition, Medical School, Universite Libre de Bruxelles, Belgium.

To compare the proportions of four muscarinic receptors in different rat brain regions, we used competition curves with four selective antagonists, at 1-[N-methyl-3H]scopolamine methyl chloride [( 3H]NMS) binding equilibrium and after allowing [3H]NMS dissociation for 35 min. Himbacine and methoctramine were shown to discriminate two muscarinic receptor subtypes having a high affinity for 4-diphenylacetoxy-N- methylpiperidine methiodide and hexahydrosiladifenidol, intermediate affinity for pirenzepine, and low affinity for AF-DX 116. One M4 subtype had a high affinity for himbacine and methoctramine; it was found predominantly in homogenates from rat striatum (46% of total [3H]NMS receptors) and in lower proportion in cortex (33% of [3H]NMS receptors) and hippocampus (16% of [3H]NMS receptors). Its binding properties were identical to those of muscarinic receptors in the neuroblastoma x glioma NG 108-15 hybrid, suggesting that it was encoded by m4 mRNA. The M3 subtype (typically found in rat pancreas, a tissue expressing the m3 mRNA) had a low affinity for himbacine and methoctramine and represented about 10% of all [3H]NMS receptors in rat brain cortex, hippocampus, striatum, and cerebellum. M1 and M2 receptors were identified in rat brain by their high affinity for pirenzepine and AF-DX 116, respectively.

Volume 38, Issue 2, pp. 267-273, 08/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. M. Clancy, S. B. Boyer, and P. A. Slesinger Coregulation of Natively Expressed Pertussis Toxin-Sensitive Muscarinic Receptors with G-Protein-Activated Potassium Channels J. Neurosci., June 13, 2007; 27(24): 6388 - 6399. [Abstract] [Full Text] [PDF]

				E. Brazhnik, R. Borgnis, R. U. Muller, and S. E. Fox The Effects on Place Cells of Local Scopolamine Dialysis Are Mimicked by a Mixture of Two Specific Muscarinic Antagonists J. Neurosci., October 20, 2004; 24(42): 9313 - 9323. [Abstract] [Full Text] [PDF]

				Y. Takayasu, M. Iino, N. Furuya, and S. Ozawa Muscarine-Induced Increase in Frequency of Spontaneous EPSCs in Purkinje Cells in the Vestibulo-Cerebellum of the Rat J. Neurosci., July 16, 2003; 23(15): 6200 - 6208. [Abstract] [Full Text] [PDF]

				C. K. Jones and H. E. Shannon Muscarinic Cholinergic Modulation of Prepulse Inhibition of the Acoustic Startle Reflex J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1017 - 1023. [Abstract] [Full Text]

				R. V. Fornari, K. M. Moreira, and M. G. M. Oliveira Effects of the Selective M1 Muscarinic Receptor Antagonist Dicyclomine on Emotional Memory Learn. Mem., September 1, 2000; 7(5): 287 - 292. [Abstract] [Full Text]

				X. M. Shao and J. L. Feldman Acetylcholine Modulates Respiratory Pattern: Effects Mediated by M3-Like Receptors in PreBotzinger Complex Inspiratory Neurons J Neurophysiol, March 1, 2000; 83(3): 1243 - 1252. [Abstract] [Full Text] [PDF]

				J. L. Ellis, D. Harman, J. Gonzalez, M. L. Spera, R. Liu, T. Y. Shen, D. M. Wypij, and F. Zuo Development of Muscarinic Analgesics Derived from Epibatidine: Role of the M4 Receptor Subtype J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1143 - 1150. [Abstract] [Full Text]

				P. Onali and M. C. Olianas Identification and Characterization of Muscarinic Receptors Potentiating the Stimulation of Adenylyl Cyclase Activity by Corticotropin-Releasing Hormone in Membranes of Rat Frontal Cortex J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 753 - 759. [Abstract] [Full Text]

				M. P. Caulfield and N. J. M. Birdsall International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors Pharmacol. Rev., June 1, 1998; 50(2): 279 - 290. [Abstract] [Full Text] [PDF]

				S. L. Purkerson and L. T. Potter Use of Antimuscarinic Toxins To Facilitate Studies of Striatal m4 Muscarinic Receptors J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 707 - 713. [Abstract] [Full Text]

				J. M. Loudon, S. M. Bromidge, F. Brown, M. S. G. Clark, J. P. Hatcher, J. Hawkins, G. J. Riley, G. Noy, and B. S. Orlek SB 202026: A Novel Muscarinic Partial Agonist with Functional Selectivity for M1 Receptors J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1059 - 1068. [Abstract] [Full Text]

				H. E. Shannon, M. J. Sheardown, F. P. Bymaster, D. O. Calligaro, N. W. Delapp, J. Gidda, C. H. Mitch, B. D. Sawyer, P. W. Stengel, J. S. Ward, et al. Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 884 - 894. [Abstract] [Full Text]

				A. U. Höglund and H. A. Baghdoyan M2, M3 and M4, but not M1, Muscarinic Receptor Subtypes are Present in Rat Spinal Cord J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 470 - 477. [Abstract] [Full Text]

				C. Liu, J. M. Ding, L. E. Faiman, and M. U. Gillette Coupling of Muscarinic Cholinergic Receptors and cGMP in Nocturnal Regulation of the Suprachiasmatic Circadian Clock J. Neurosci., January 15, 1997; 17(2): 659 - 666. [Abstract] [Full Text] [PDF]